Tilray Brands, Inc. 8-K Filing

From the Filing

EDGAR Filing Documents for 0001171843-26-002136 This page uses Javascript. Your browser either doesn't support Javascript or you have it turned off. To see this page as it is meant to appear please use a Javascript enabled browser. SEC.gov EDGAR Latest Filings Filings search tools Filing Detail SEC Home » Company Search » Current Page Form 8-K - Current report: SEC Accession No. 0001171843-26-002136 Filing Date 2026-04-01 Accepted 2026-04-01 07:00:14 Documents 13 Period of Report 2026-04-01 Items Item 2.02: Results of Operations and Financial Condition Item 9.01: Financial Statements and Exhibits Interactive Data Document Format Files Seq Description Document Type Size 1 FORM 8-K f8k_040126.htm iXBRL 8-K 14928 2 PRESS RELEASE exh_991.htm EX-99.1 694221 Complete submission text file 0001171843-26-002136.txt 942098 Data Files Seq Description Document Type Size 3 XBRL SCHEMA FILE gnw-20250101.xsd EX-101.SCH 3402 4 XBRL DEFINITION FILE gnw-20250101_def.xml EX-101.DEF 26066 5 XBRL LABEL FILE gnw-20250101_lab.xml EX-101.LAB 35956 6 XBRL PRESENTATION FILE gnw-20250101_pre.xml EX-101.PRE 24702 16 EXTRACTED XBRL INSTANCE DOCUMENT f8k_040126_htm.xml XML 2844 Mailing Address 655 MADISON AVENUE 19TH FLOOR NEW YORK NY 10065 Business Address 655 MADISON AVENUE 19TH FLOOR NEW YORK NY 10065 519.322.8800 Tilray Brands, Inc. (Filer) CIK : 0001731348 (see all company filings) EIN. : 824310622 | Fiscal Year End: 0531 Type: 8-K | Act: 34 | File No.: 001-38594 | Film No.: 26824648 SIC : 2833 Medicinal Chemicals & Botanical Products (CF Office: 03 Life Sciences)